MIRA INFORM REPORT

 

 

Report No. :

306342

Report Date :

07.02.2015

 

IDENTIFICATION DETAILS

 

Name :

JUBILANT DRAXIMAGE LIMITED (w.e.f. 19.10.2010)

 

 

Formerly Known As :

DRAXIMAGE INDIA LIMITED

 

 

Registered Office :

1A, Sector-16A, Institutional Area, Noida – 201301, Uttar Pradesh

 

 

Country :

India

 

 

Financials (as on) :

31.03.2014

 

 

Date of Incorporation :

09.09.2009

 

 

Com. Reg. No.:

20-038194

 

 

Capital Investment / Paid-up Capital :

Rs. 0.781 Million

 

 

CIN No.:

[Company Identification No.]

U74900UP2009FLC038194

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

Not Available

 

 

PAN No.:

[Permanent Account No.]

AADCD2306C

 

 

Legal Form :

A Closely Held Public Limited Liability Company.

 

 

Line of Business :

Subject is engaged in marketing of innovative diagnostic imaging radiopharmaceutical solution and therapeutic radiopharmaceutical products.

 

 

No. of Employees :

Not Available

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ca (12)

 

RATING

STATUS

PROPOSED CREDIT LINE

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

Limited with full security

 

Status :

Moderate

 

 

Payment Behaviour :

Slow

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having moderate track record.

 

The company has incurred huge accumulated losses which has eroded net worth of the company. Liquidity position of the company is under pressure.

 

Business is active. Payments are reported to be slow.

 

The company can be considered for business dealings on safe and secured trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – December 31, 2014

 

Country Name

Previous Rating

(30.09.2014)

Current Rating

(31.12.2014)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

 

 

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

EXTERNAL AGENCY RATING

 

 

Rating Agency Name

Not Available

Rating

Not Available

Rating Explanation

Not Available

Date

Not Available

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2014.

 

 

LOCATIONS

 

Registered Office :

1A, Sector-16A, Institutional Area, Noida – 201301, Uttar Pradesh, India

Tel. No.:

91-120-2516601/11

Fax No.:

91-120-4361769

E-Mail :

secretarial_draximageindia@jubl.com

pharmacovigilance@jdi.jubl.com

customerservice@jdi.jubl.com

Website :

http://www.draximage.com

 

 

DIRECTORS

 

As on: 01.09.2014

 

Name :

Mr. Amit Arora

Designation :

Director

Address :

41, Prayag Apartments, Vasundhra Enclave, New Delhi – 110096, India

Date of Birth/Age :

25.04.1971

Date of Appointment :

24.08.2012

DIN No.:

05189254

 

 

Name :

Mr. Muraleedharan Ajithkumar

Designation :

Whole-time director

Address :

Flat No. 302, 2nd Floor, Gagan Maitre, #10, 4th Cross, Doddamma Layout, Manorayan Apaly, Bangalore – 560032, Karnataka, India

Date of Appointment :

01.06.2012

DIN No.:

05309579

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on: 01.09.2014

 

Names of Shareholders

 

No. of Shares

Draximage Limited, India

 

78080

Draximage Limited Jointly with Rajagopal Sankaraiah

 

1

Draximage Limited Jointly with Lalit Jain

 

1

Draximage Limited Jointly with Ashwani Malhotra

 

1

Draximage Limited Jointly with Arun Kumar Sharma

 

1

Draximage Limited Jointly with Ambuj Jains

 

1

Draximage Limited Jointly with Praveen Gupta

 

1

Total

 

78086

 

Equity Share Break up (Percentage of Total Equity)

 

As on: 01.09.2014

 

Category

Percentage

Foreign holdings( Foreign institutional investor(s), Foreign companie(s) Foreign financial institution(s), Non-resident Indian(s) or Overseas Corporate bodies or Others

100.00

Total

100.00

 

 

 

BUSINESS DETAILS

 

Line of Business :

Subject is engaged in marketing of innovative diagnostic imaging radiopharmaceutical solution and therapeutic radiopharmaceutical products.

 

 

Products :

Therapeutic Radiopharmaceutical Products

 

 

Brand Names :

Not Available

 

 

Agencies Held :

Not Available

 

 

Exports :

Not Available

 

 

Imports :

Not Available

 

 

Terms :

Not Available

 

 

GENERAL INFORMATION

 

Suppliers :

Reference :

Not Available

Name of the Person :

Not Available

Contact No.:

Not Available

Since How Long Known :

Not Available

Maximum Limit Dealt :

Not Available

Experience :

Not Available

Remark:

Not Available

 

 

Customers :

Reference :

Not Available

Name of the Person :

Not Available

Contact No.:

Not Available

Since How Long Known :

Not Available

Maximum Limit Dealt :

Not Available

Experience :

Not Available

Remark:

Not Available

 

 

No. of Employees :

Not Available

 

 

Bankers :

Not Available

 

 

Facilities :

Secured Loan

31.03.2014

(Rs. in Millions)

31.03.2013

(Rs. in Millions)

Long-term Borrowings

 

 

Long-term maturities of finance lease

(*(Finance lease obligations were secured by hypothecation of specific vehicle taken on such lease).)

0.557

0.000

 

Auditors :

 

Name :

BSR and Company, LLP

Chartered Accountants

Address :

Building No. 10, 8th Floor, Tower-B, DLF Cyber City, Phase-II, Gurgaon -122002, Haryana, India

PAN N Income-tax PAN of auditor or auditor's firm :

AAAFB9852F

 

 

Memberships :

Not Available

 

 

Collaborators :

Not Available

 

 

Fellow Subsidiaries:

Jubilant Draximage Inc, Canada

 

 

Intermediate Holding Company:

Jubilant Pharma Private Limited, Singapore

 

 

Ultimate Holding company:

Jubilant Life Sciences Limited, India

CIN: L24116UP1978PLC004624

 

 

Holding company:

Draximage Limited, Cyprus

 

 

CAPITAL STRUCTURE

 

As on 31.03.2014

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

200,000

Equity Shares

Rs.10/- each

Rs. 2.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

78,086

Equity Shares

Rs.10/- each

Rs. 0.781 Millions

 

 

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2014

31.03.2013

31.03.2012

I.        EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

0.781

0.781

0.780

(b) Reserves & Surplus

(26.892)

(14.556)

(3.346)

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

(26.111)

(13.775)

(2.566)

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) Long-term borrowings

0.557

0.000

0.913

(b) Deferred tax liabilities (Net)

0.000

0.000

0.000

(c) Other long term liabilities

0.724

0.297

0.621

(d) long-term provisions

0.000

0.000

0.000

Total Non-current Liabilities (3)

1.281

0.297

1.534

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

0.000

0.000

0.000

(b) Trade payables

45.766

30.778

15.830

(c) Other current liabilities

2.593

1.795

4.590

(d) Short-term provisions

0.060

0.046

0.279

Total Current Liabilities (4)

48.419

32.619

20.699

 

 

 

 

TOTAL

23.589

19.141

19.667

 

 

 

 

II.      ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

1.048

0.281

1.065

(ii) Intangible Assets

0.005

0.008

0.011

(iii) Capital work-in-progress

0.000

0.000

2.514

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

0.000

0.000

0.000

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d)  Long-term Loan and Advances

0.951

1.004

0.955

(e) Other Non-current assets

0.476

1.261

0.471

Total Non-Current Assets

2.480

2.554

5.016

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

1.148

2.545

0.428

(c) Trade receivables

10.431

8.028

9.765

(d) Cash and cash equivalents

6.411

3.775

3.274

(e) Short-term loans and advances

2.982

2.167

0.980

(f) Other current assets

0.137

0.072

0.204

Total Current Assets

21.109

16.587

14.651

 

 

 

 

TOTAL

23.589

19.141

19.667

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2014

31.03.2013

31.03.2012

 

SALES

 

 

 

 

 

Revenue from Operations

91.379

91.525

72.074

 

 

Other Income

0.173

0.101

0.018

 

 

TOTAL                                     (A)

91.552

91.626

72.092

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Purchases of Stock-in-Trade

69.625

76.996

58.279

 

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

1.397

(2.118)

0.180

 

 

Employees benefits expense

12.085

10.092

7.293

 

 

Other expenses

18.290

16.833

12.798

 

 

TOTAL (B)

101.397

101.803

78.550

 

 

Purchases of Stock-in-Trade

69.625

76.996

58.279

 

 

 

 

 

Less

PROFIT/ (LOSS) BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

(9.845)

(10.177)

(6.458)

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

0.062

0.007

0.000

 

 

 

 

 

 

PROFIT/ (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                               (E)

(9.907)

(10.184)

(6.458)

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

2.429

1.025

0.080

 

 

 

 

 

 

PROFIT/ (LOSS) BEFORE TAX (E-F)                  (G)

(12.336)

(11.209)

(6.538)

 

 

 

 

 

Less

TAX                                                                  (H)

0.000

0.000

0.000

 

 

 

 

 

 

PROFIT/ (LOSS) AFTER TAX (G-H)                   (I)

(12.336)

(11.209)

(6.538)

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

TOTAL EARNINGS

2.790

4.299

0.021

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Stock in trade

59.178

69.324

53.640

 

TOTAL IMPORTS

59.178

69.324

53.640

 

 

 

 

 

 

Earnings/ (Loss) Per Share (Rs.)

(0.16)

(0.14)

(85.00)

 

 

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2014

31.03.2013

31.03.2012

Net Profit Margin

(PAT/Sales)

(%)

(13.50)

(12.25)

(9.07)

 

 

 

 

 

Operating Profit Margin

(PBDIT/Sales)

(%)

(10.77)

(11.12)

(8.96)

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

(52.30)

(58.56)

(38.12)

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.47

0.81

2.55

 

 

 

 

 

Debt Equity Ratio

(Total Debt/Networth)

 

(0.02)

0.00

(0.36)

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

0.44

0.51

0.71

 


 

FINANCIAL ANALYSIS

[all figures are in Rupees Millions]

 

DEBT EQUITY RATIO

 

Particular

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Share Capital

0.780

0.781

0.781

Reserves & Surplus

(3.346)

(14.556)

(26.892)

Net worth

(2.566)

(13.775)

(26.111)

 

 

 

 

long-term borrowings

0.913

0.000

0.557

Short term borrowings

0.000

0.000

0.000

Total borrowings

0.913

0.000

0.557

Debt/Equity ratio

(0.356)

0.000

(0.021)

 

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Sales

72.074

91.525

91.379

 

 

26.988

(0.160)

 

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Sales

72.074

91.525

91.379

Profit/(Loss)

(6.538)

(11.209)

(12.336)

 

(9.07%)

(12.25%)

(13.50%)

 

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

No

9]

Name of person contacted

No

10]

Designation of contact person

No

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

--

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

--

22]

Litigations that the firm / promoter involved in

--

23]

Banking Details

No

24]

Banking facility details

No

25]

Conduct of the banking account

--

26]

Buyer visit details

--

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

 

OPERATIONS:

 

The company is engaged in marketing of innovative diagnostic imaging radiopharmaceutical solution and therapeutic radiopharmaceutical products. It has launched the Lyophilized kits MDP, MAA and Sestamibi and would soon be launching DTPA and DMSA. It is also involved in distribution of wide range of radioisotopes which include Tc-99m Generator (used in the diagnosis of Bone Cancer, Renal Imaging, Cerebral Perfusion Imaging, and Myocardial Perfusion Imaging), Thallium-201 and Iodine-131 capsules and solution (for the diagnosis and treatment of Thyroid and its related disease), Lutetium-177, Gallium-68 generator and Rhenium-188 generator via various partnerships across the world. The target customers are Nuclear Medicine physicians, Cardiologists and Oncologists of various hospitals and imaging labs.

 

 

INDEX OF CHARGES: NO CHARGES EXIST FOR COMPANY

 

 

FIXED ASSETS:

 

·         Furniture and fixtures

·         Vehicles

·         Office equipment

·         Computer software

 


 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.61.74

UK Pound

1

Rs.94.65

Euro

1

Rs.70.79

 

 

INFORMATION DETAILS

 

Analysis Done by :

KRN

 

 

Report Prepared by :

MTN


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

2

PAID-UP CAPITAL

1~10

2

OPERATING SCALE

1~10

2

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

2

--PROFITABILITY

1~10

-

--LIQUIDITY

1~10

2

--LEVERAGE

1~10

2

--RESERVES

1~10

-

--CREDIT LINES

1~10

-

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

NO

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

12

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

 

 

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.